↓ Skip to main content

Dove Medical Press

Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder

Overview of attention for article published in Neuropsychiatric Disease and Treatment, May 2011
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (71st percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

policy
1 policy source
wikipedia
1 Wikipedia page

Citations

dimensions_citation
42 Dimensions

Readers on

mendeley
78 Mendeley
Title
Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder
Published in
Neuropsychiatric Disease and Treatment, May 2011
DOI 10.2147/ndt.s18333
Pubmed ID
Authors

Robert Berman, Robert Berman, Michael Thase, Madhukar Trivedi, Hazel, Marler, McQuade, Carson, Ross A. Baker, ronald marcus

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 78 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 1%
Canada 1 1%
Unknown 76 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 13 17%
Student > Bachelor 13 17%
Other 8 10%
Student > Postgraduate 6 8%
Student > Ph. D. Student 5 6%
Other 16 21%
Unknown 17 22%
Readers by discipline Count As %
Medicine and Dentistry 22 28%
Psychology 13 17%
Pharmacology, Toxicology and Pharmaceutical Science 7 9%
Neuroscience 6 8%
Agricultural and Biological Sciences 5 6%
Other 8 10%
Unknown 17 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 November 2016.
All research outputs
#5,446,994
of 25,374,917 outputs
Outputs from Neuropsychiatric Disease and Treatment
#767
of 3,132 outputs
Outputs of similar age
#27,032
of 121,552 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#6
of 18 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,132 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has gotten more attention than average, scoring higher than 74% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 121,552 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.